WHO ICTRP trial
To study the safety,tolerability and effect of Pilocarpine Hydrochloride…
CTRI/2025/07/090630 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/07/090630 |
|---|---|
| Public title | To study the safety,tolerability and effect of Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25 percentage w/v for the treatment in Participants with Presbyopia. |
| Scientific title | A Multicenter, Open Label, Single-Arm, Phase IV Clinical Study to Evaluate the Safety, Tolerability and Efficacy of Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25 percentage w/v for the treatment in Participants with Presbyopia. - NIL |
| Primary sponsor | Entod Pharmaceuticals Ltd. |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: H524- Presbyopia |
| Interventions | Intervention1: Pilocarpine Hydrochloride Ophthalmic solution USP 1.25 % w/v: One drop of Pilocarpine Hydrochloride Ophthalmic solution USP 1.25 % w/v once daily in each eye (preferably in morning) for 120 days of treatment duration. Control… |
| Registration date | Oct 7, 2025 |
| Target size | 206 |
| Secondary IDs | BCR-EPL-003, Version 2.0, 1st amendment, dated 24 Apr 2025 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: